Year ended 31 December 2020
Export to Excel| Assets/ liabilities at fair value through profit or loss |
Financial assets at amortized cost |
Financial liabilities at amortized cost |
Hedging instruments |
Financial assets/liabilities excluded from the scope of IFRS 9 |
Total | |
|---|---|---|---|---|---|---|
| Dividends and shares in profits | 6,176 | – | – | – | – | 6,176 |
| Interest income / (expense) | 4,158 | 20,669 | (206,080) | (29,465) | (46,792) | (257,510) |
| Currency translation differences | (4,713) | 7,864 | (249,503) | – | – | (246,352) |
| Impairment / revaluation | 111,441 | (223,200) | (12,919) | (34) | – | (124,712) |
| Commission relating to borrowings and debt securities |
– | – | (18,162) | – | – | (18,162) |
| Gain/(loss) on disposal of investments | 2,074 | (4,547) | – | – | – | (2,473) |
| Gain/(loss) on exercised derivative instruments* |
11,838 | – | – | – | – | 11,838 |
| Net financial income (costs) | 130,974 | (199,214) | (486,664) | (29,499) | (46,792) | (631,195) |
| Revaluation | (1,926) | (57,697) | – | – | – | (59,623) |
| Gain/(loss) on exercised derivative instruments* |
(136,382) | – | – | – | – | (136,382) |
| Net operating income/(costs) | (138,308) | (57,697) | – | – | – | (196,005) |
| Remeasurement | – | – | – | (103,172) | – | (103,172) |
| Other comprehensive income | – | – | – | (103,172) | – | (103,172) |
* The Group recognises income and expense from commodity derivatives in operating activities. Revenue and expenses regarding other derivatives are recognized under financial revenue/expenses.
Year ended 31 December 2019 (restated figures)
Export to Excel| Assets/ liabilities at fair value through profit or loss |
Financial assets at amortized cost |
ZFinancial liabilities at amortized cost |
Hedging instruments |
Financial assets/liabilities excluded from the scope of IFRS 9 |
Total | |
|---|---|---|---|---|---|---|
| Dividends and shares in profits | 4,254 | – | – | – | – | 4,254 |
| Interest income / (expense) | 7,414 | 20,902 | (205,674) | 743 | (41,901) | (218,516) |
| Currency translation differences | 4,007 | (3,128) | 29,200 | – | – | 30,079 |
| Impairment / revaluation | (26,952) | (602) | (3,271) | 34 | – | (30,791) |
| Commission relating to borrowings and debt securities |
– | – | (20,338) | – | – | (20,338) |
| Gain/(loss) on disposal of investments | 17 | (1,974) | – | – | – | (1,957) |
| Gain/(loss) on exercised derivative instruments* |
(18,144) | – | – | – | – | (18,144) |
| Net financial income (costs) | (29,404) | 15,198 | (200,083) | 777 | (41,901) | (255,413) |
| Revaluation | 21,386 | (27,818) | – | – | – | (6,432) |
| Gain/(loss) on exercised derivative instruments* |
(34,054) | – | – | – | – | (34,054) |
| Net operating income/(costs) | (12,668) | (27,818) | – | – | – | (40,486) |
| Remeasurement | – | – | – | 15,179 | – | 15,179 |
| Other comprehensive income | – | – | – | 15,179 | – | 15,179 |
* The Group recognises income and expenses from commodity derivatives in operating activities. Revenue and expenses regarding other derivatives are recognized under financial revenue/expenses.